Amendment to RFA-CA-07-012, Clinical Proteomic Technology Assessment for Cancer (U24)

Notice Number: NOT-CA-06-018

Key Dates
Release Date: March 17, 2006

Issued by
National Cancer Institute (NCI), (http://www.nci.nih.gov)

Amendment

This Notice is to inform the scientific community that the NCI has extended the Letter of Intent Receipt Date and Application Receipt Date for Request for Applications (RFA) CA-07-012, "Clinical Proteomic Technology Assessment for Cancer (U24) (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-07-012.html), which was issued as part of the NCI Clinical Proteomic Technology Initiative for Cancer (http://proteomics.cancer.gov), in order to give interested applicants 2 additional weeks to prepare and submit their applications. The new dates are as follows:

Letter of Intent Receipt Date: April 8, 2006
Application Receipt Date: May 8, 2006

Other key dates remained unchanged and are as follows:

Peer Review Date(s): June/July 2006
Council Review Date(s): September/October 2006
Earliest Anticipated Start Date: September 26, 2006
Additional Information To Be Available Date (URL Activation Date): Not Applicable.
Expiration Date: May 9, 2006

Inquiries

Direct questions about this change to:
Gregory J. Downing, D.O., Ph.D.
Office of Technology and Industrial Relations
National Cancer Institute
Building 31, Room 10A52, MSC 2580
Bethesda, MD 20892-2580
Telephone: (301) 496-1550
Fax: (301) 496-7807
Email: [email protected]